Monopar Therapeutics(MNPR) - 2023 Q4 - Annual Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Address of principal executive offices) (Zip Code) (847) 388-0349 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 28, 2024 MONOPAR THERAPEUTICS INC. (Exact name of registrant as specified in its charter) | Delaware | 001-39070 | 32-0463781 | | --- | --- | --- | | (State or other jurisdiction | (Commission | (I.R.S. Employer | | of inc ...